Compare ABCL & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | MAN |
|---|---|---|
| Founded | 2012 | 1948 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2020 | 1994 |
| Metric | ABCL | MAN |
|---|---|---|
| Price | $7.87 | $33.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $8.40 | ★ $35.67 |
| AVG Volume (30 Days) | ★ 7.1M | 1.1M |
| Earning Date | 05-11-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $75,128,000.00 | ★ $17,957,100,000.00 |
| Revenue This Year | N/A | $5.12 |
| Revenue Next Year | $21.85 | $3.42 |
| P/E Ratio | ★ N/A | $675.40 |
| Revenue Growth | ★ 160.56 | 0.58 |
| 52 Week Low | $2.75 | $25.15 |
| 52 Week High | $8.42 | $47.34 |
| Indicator | ABCL | MAN |
|---|---|---|
| Relative Strength Index (RSI) | 73.27 | 53.65 |
| Support Level | $3.32 | $28.29 |
| Resistance Level | N/A | $36.87 |
| Average True Range (ATR) | 0.53 | 1.64 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 83.58 | 38.49 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.